Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer
NCT05351021Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Apr 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metformin in peripheral neuropathy, sponsored by Mansoura University. Primary endpoint: Incidence of grade II or more peripheral neuropathy at 8 weeks. Started Apr 2022; status: completed.
02
Drugs
metformin
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT05351021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351021.